Christopher Mutz, HEAD OF RARE DISEASE at ANI PHARMACEUTICALS INC (ANIP), sold 3,162 shares at $71.64 ($227K) on 2026-03-13, disclosed to the SEC on 2026-03-13.
Seasonal sale ($227k) by HEAD OF RARE DISEASE — this insider has traded ANIP in March in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ANIP | SELL | 2026-02-23 | $415K | — | Filing → |
| ANIP | SELL | 2026-02-17 | $538K | — | Filing → |
| ANIP | SELL | 2025-05-15 | $242K | — | Filing → |